| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213
White female rats were given injections i.v. or i.p. of actinomycin D and the sequence of nucleolar segregation or reorganization in hepatic cells was documented. Subsequent to i.v. injection of 1.25 µg/g, the earliest nucleolar alteration is the accumulation of dense plaques within nucleolar vacuoles and in the region of the nucleolus-associated chromatin. At 10 min these plaques enlarge, and at 20 min they appear to coalesce, with some separation of the fibrillar and particulate components. Nucleolar segregation is more completely developed at 30 min, but it requires between 30 min and 1 hr for complete development. Following i.p. injection of 0.1 µg or 0.3 µg/g, actinomycin D produces only partial segregation, which most frequently appears as a peripheral fibrillar zone with a central particulate area. Restoration of normal nucleolar structure takes place between 105 and 140 min after 0.1 µg/g and begins about 6 hr after 0.3 µg/g although it is not entirely completed until 12 to 24 hr after this dose. During recovery from the 2 lower doses, it appears that the fibrillar component of the nucleolonema is reconstituted first. It is suggested that nucleolar segregation may be brought about by contraction of the intra-and extranucleolar chromatin with a concomitant separation of the attached fibrillar components from the separated particulate components. It is also suggested that the nucleolar particles represent the coiled ends of the fibrils.
1 Supported by Research Grant CA 10686 from the National Cancer Institute and by Research Grant GM-10629 and Training Grant GM 135 from the National Institute of Medical Sciences, NIH.
2 During this research Dr. Goldblatt had a faculty research award from the American Cancer Society, Inc. (Grant PRA-60). Present address: Department of Pathology, University of Connecticut Medical Center, Farmington, Conn. 06032.
3 During this work, Dr. Sullivan was a postdoctoral fellow of the NIH under Grant 1-F2-GM-32,395.
Received 8/12/69. Accepted 12/18/69.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |